Multiple sclerosis: open trials in Serbia

3 open trials have a site in Serbia. Registry data; only the trial team decides who can take part.

NCT07067463
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Trial Treatment · Phase 3 · Zenas BioPharma (USA), LLC
University Clinical Centre of Serbia, Belgrade · University Clinical Centre of Kragujevac, Kragujevac · Clinical Centre Kragujevac, Neurology clinic, Kragujevac · Clinic of Neurology - Clinical Center Nis, Niš
Registry updated 2026-11-03
NCT07503873
A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection Sites and Relative Bioavailability Via Autoinjector (AI) Versus Syringe Subcutaneously in Participants With Multiple Sclerosis (MS)
Trial Treatment · Phase 2 · TG Therapeutics, Inc.
TG Therapeutics Investigational Trial Site, Belgrade · TG Therapeutics Investigational Trial Site, Kragujevac
Registry updated 2026-10-29
NCT07299019
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Trial Treatment · Phase 3 · Zenas BioPharma (USA), LLC
University Clinical Centre of Kragujevac, Kragujevac · Clinic of Neurology - Clinical Center Nis, Niš
Registry updated 2026-10-27

This page is not medical advice. Talk to your doctor before contacting a trial.

A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis